Michael Cruse - Aug 29, 2022 Form 4 Insider Report for Reneo Pharmaceuticals, Inc. (RPHM)

Signature
/s/ Michael Cruse
Stock symbol
RPHM
Transactions as of
Aug 29, 2022
Transactions value $
$23,243
Form type
4
Date filed
8/31/2022, 05:47 PM
Previous filing
Mar 4, 2022
Next filing
Sep 2, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RPHM Common Stock Purchase $269 +83 +0.27% $3.24 30.8K Aug 29, 2022 Direct F1
transaction RPHM Common Stock Purchase $3.69K +1.14K $3.24 1.14K Aug 29, 2022 by Trust F2
transaction RPHM Common Stock Purchase $3.08K +975 +3.17% $3.16 31.8K Aug 30, 2022 Direct F3
transaction RPHM Common Stock Purchase $5.89K +1.85K +161.84% $3.19 2.99K Aug 30, 2022 by Trust F2, F4
transaction RPHM Common Stock Purchase $10.3K +3.21K +107.6% $3.21 6.2K Aug 31, 2022 by Trust F2, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 1,600 shares acquired under the Issuer's 2021 Employee Stock Purchase Plan on June 8, 2022.
F2 By Michael P. Cruse and Thu Anh Thuy Cruse, Trustees of The Cruse Family Revocable Living Trust.
F3 The weighted average purchase price for the transaction was $3.16. The shares were purchased at a range of prices between $3.11 and $3.19. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided.
F4 The weighted average purchase price for the transaction was $3.1938. The shares were purchased at a range of prices between $3.16 and $3.25. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided.
F5 The weighted average purchase price for the transaction was $3.209. The shares were purchased at a range of prices between $3.19 and $3.29. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided.